AAAAAA

   
Results: 1-13 |
Results: 13
DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS
Authors: KRAMER MS CUTLER N FEIGHNER J SHRIVASTAVA R CARMAN J SRAMEK JJ REINES SA LIU GH SNAVELY D WYATTKNOWLES E HALE JJ MILLS SG MACCOSS M SWAIN CJ HARRISON T HILL RG HEFTI F SCOLNICK EM CASCIERI MA CHICCHI GG SADOWSKI S WILLIAMS AR HEWSON L SMITH D CARLSON EJ HARGREAVES RJ RUPNIAK NMJ
Citation: Ms. Kramer et al., DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS, Science, 281(5383), 1998, pp. 1640-1645
A PLACEBO-CONTROLLED CROSSOVER STUDY OF RIZATRIPTAN IN THE TREATMENT OF MULTIPLE MIGRAINE ATTACKS
Authors: KRAMER MS MATZURAWOLFE D POLIS A GETSON A AMARANENI PG SOLBACH MP MCHUGH W FEIGHNER J SILBERSTEIN S REINES SA
Citation: Ms. Kramer et al., A PLACEBO-CONTROLLED CROSSOVER STUDY OF RIZATRIPTAN IN THE TREATMENT OF MULTIPLE MIGRAINE ATTACKS, Neurology, 51(3), 1998, pp. 773-781
THE SUBSTANCE-P RECEPTOR ANTAGONIST L-754,030 (MK-0869) IS INEFFECTIVE IN THE TREATMENT OF POSTHERPETIC NEURALGIA
Authors: BLOCK GA RUE D PANEBIANCO D REINES SA
Citation: Ga. Block et al., THE SUBSTANCE-P RECEPTOR ANTAGONIST L-754,030 (MK-0869) IS INEFFECTIVE IN THE TREATMENT OF POSTHERPETIC NEURALGIA, Neurology, 50(4), 1998, pp. 4084-4084
VALIDATION OF A QUESTIONNAIRE FOR COMPARING THE TOLERABILITY OF OPHTHALMIC MEDICATIONS
Authors: BARBER BL STRAHLMAN ER LAIBOVITZ R GUESS HA REINES SA
Citation: Bl. Barber et al., VALIDATION OF A QUESTIONNAIRE FOR COMPARING THE TOLERABILITY OF OPHTHALMIC MEDICATIONS, Ophthalmology, 104(2), 1997, pp. 334-342
PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF RIZATRIPTAN IN MULTIPLE ATTACKS OF ACUTE MIGRAINE
Authors: KRAMER MS MATZURAWOLFE D GETSON A POLIS A REINES SA
Citation: Ms. Kramer et al., PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF RIZATRIPTAN IN MULTIPLE ATTACKS OF ACUTE MIGRAINE, Neurology, 48(3), 1997, pp. 1136-1136
THE EFFECTS OF A SELECTIVE D-4 DOPAMINE-RECEPTOR ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC INPATIENTS WITH SCHIZOPHRENIA
Authors: KRAMER MS LAST B GETSON A REINES SA SILVA JA WIRSHING W CONLEY R ALLAN E CHENG HY CHAVEZENG C
Citation: Ms. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 DOPAMINE-RECEPTOR ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC INPATIENTS WITH SCHIZOPHRENIA, Archives of general psychiatry, 54(6), 1997, pp. 567-572
PILOT-STUDY OF MK-462 IN MIGRAINE
Authors: CUTLER NR CLAGHORN J SRAMEK JJ BLOCK G PANEBIANCO D CHENG H OLAH TV REINES SA
Citation: Nr. Cutler et al., PILOT-STUDY OF MK-462 IN MIGRAINE, Cephalalgia, 16(2), 1996, pp. 113-116
MK-462 IN MIGRAINE - A PILOT-STUDY
Authors: CUTLER NR CLAGHORN J SRAMEK JJ BLOCK G PANEBIANCO D CHENG H OLAH TV REINES SA
Citation: Nr. Cutler et al., MK-462 IN MIGRAINE - A PILOT-STUDY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 32-32
RIZATRIPTAN VS SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY
Authors: VISSER WH TERWINDT GM REINES SA JIANG K LINES CR FERRARI MD
Citation: Wh. Visser et al., RIZATRIPTAN VS SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY, Archives of neurology, 53(11), 1996, pp. 1132-1137
A 6-WEEK DOSE-RESPONSE STUDY OF THE OCULAR HYPOTENSIVE EFFECT OF DORZOLAMIDE WITH A ONE-YEAR EXTENSION
Authors: STRAHLMAN E TIPPING R VOGEL R ABRANTES P ALM A AIRAKSINEN PJ BARNEBEY H BORGEOIS A COHEN JS COLLIGNONBRANCH J CYRLIN MN DEMAILLY P EHINGER B GEORGE JL GREVE E GROSS RL HIGGINBOTHAM EJ KASS MA LAIBOVITZ RA LANGE U LEWIS RA MACLURE G MCMAHON CD MANDELKORN RM SCHUMAN JS SERLE J SKUTA G TOLIA J WEINREB R WILENSKY J ZIMMERMAN TJ CLINESCHMIDT CM LIPPA EA REINES SA STROHMAIER KM
Citation: E. Strahlman et al., A 6-WEEK DOSE-RESPONSE STUDY OF THE OCULAR HYPOTENSIVE EFFECT OF DORZOLAMIDE WITH A ONE-YEAR EXTENSION, American journal of ophthalmology, 122(2), 1996, pp. 183-194
PILOT-STUDY OF A CCKB ANTAGONIST IN PATIENTS WITH PANIC DISORDER - PRELIMINARY FINDINGS
Authors: SRAMEK JJ KRAMER MS REINES SA CUTLER NR
Citation: Jj. Sramek et al., PILOT-STUDY OF A CCKB ANTAGONIST IN PATIENTS WITH PANIC DISORDER - PRELIMINARY FINDINGS, Anxiety, 1(3), 1994, pp. 141-143
A MULTIPLE-DOSE SAFETY TRIAL OF EPTASTIGMINE IN ALZHEIMERS-DISEASE, WITH PHARMACODYNAMIC OBSERVATIONS OF RED-BLOOD-CELL CHOLINESTERASE
Authors: SRAMEK JJ BLOCK GA REINES SA SAWIN SF BARCHOWSKY A CUTLER NR
Citation: Jj. Sramek et al., A MULTIPLE-DOSE SAFETY TRIAL OF EPTASTIGMINE IN ALZHEIMERS-DISEASE, WITH PHARMACODYNAMIC OBSERVATIONS OF RED-BLOOD-CELL CHOLINESTERASE, Life sciences, 56(5), 1994, pp. 319-326
PLACEBO-CONTROLLED STUDY OF A CCKB ANTAGONIST IN PATENTS WITH PANIC DISORDER
Authors: CUTLER NR SRAMEK JJ KRAMER MS REINES SA
Citation: Nr. Cutler et al., PLACEBO-CONTROLLED STUDY OF A CCKB ANTAGONIST IN PATENTS WITH PANIC DISORDER, Biological psychiatry, 35(9), 1994, pp. 680-680
Risultati: 1-13 |